http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-37201-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f9afcd0369d6402247555a4656c0917
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-70
filingDate 1972-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1977-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-37201-B1
titleOfInvention Substituted piperidinoalkanone oxime derivatives
abstract 1413139 Pharmaceutical aerosol compositions RICHARDSON-MERRELL Inc 15 Dec 1972 [28 Jan 1972] 57996/72 Heading C4X [Also in Division C2] Pharmaceutical compositions in the form of aerosols comprise a compound of Formula I in which R is H or OH, R 1 is H or R and R 1 taken together form a second bond, n is 1-3 and Z is thienyl, phenyl or phenyl substituted by halo, 1-4C alkyl, 1-4C alkoxy, di(1-4C alkyl)- amino or a saturated monocyclic heterocyclic ring; and a gaseous or liquefied propellant such as Cl 2 CF 2 , optionally mixed with C 2 H 2 Cl 2 F 2 , together with any co-solvents or wetting agents as may be necessary.n[GB1413139A]
priorityDate 1972-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811

Total number of triples: 16.